Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in Pediatr Infect Dis J

Retrieve available abstracts of 74 articles:
HTML format
Text format



Single Articles


    June 2017
  1. KEKITIINWA A, Szubert AJ, Spyer M, Katuramu R, et al
    Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.
    Pediatr Infect Dis J. 2017;36:588-594.
    PubMed     Text format     Abstract available


    May 2017
  2. PRASITSUEBSAI W, Sophonphan J, Chokephaibulkit K, Wongsawat J, et al
    Treatment Outcomes of Third-Line Antiretroviral Regimens in HIV-Infected Thai Adolescents.
    Pediatr Infect Dis J. 2017 May 16. doi: 10.1097/INF.0000000000001638.
    PubMed     Text format     Abstract available


  3. NAIK NM, Mbwanji RN, Mgawe M, Ongoa R, et al
    Pharmaceutical Dosing Errors at a Pediatric HIV Clinic in Mwanza, Tanzania.
    Pediatr Infect Dis J. 2017 May 11. doi: 10.1097/INF.0000000000001639.
    PubMed     Text format     Abstract available


  4. GONDRIE IPE, Bastiaans DET, Fraaij PLA, Driessen GJA, et al
    Sustained Viral Suppression in HIV-Infected Children on Once-Daily Lopinavir/ritonavir in Clinical Practice.
    Pediatr Infect Dis J. 2017 May 4. doi: 10.1097/INF.0000000000001627.
    PubMed     Text format     Abstract available


  5. JOAO EC, Gouvea MI, Teixeira ML, Mendes-Silva W, et al
    Zika Virus Infection Associated With Congenital Birth Defects in a HIV-infected Pregnant Woman.
    Pediatr Infect Dis J. 2017;36:500-501.
    PubMed     Text format     Abstract available


  6. LAZARUS E, Nicol S, Frigati L, Penazzato M, et al
    Second- and Third-line Antiretroviral Therapy for Children and Adolescents: A Scoping Review.
    Pediatr Infect Dis J. 2017;36:492-499.
    PubMed     Text format     Abstract available


  7. MAJEKODUNMI AO, Thorne C, Malyuta R, Volokha A, et al
    Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
    Pediatr Infect Dis J. 2017;36:e123-e129.
    PubMed     Text format     Abstract available


    April 2017
  8. LAPPHRA K, Oungkananukit P, Saihongthong S, Phongsamart W, et al
    Persistence of Hepatitis B Immunity Following 3-Dose Infant Primary Series in HIV-Infected Thai Adolescents and Immunologic Response to Revaccination.
    Pediatr Infect Dis J. 2017 Apr 17. doi: 10.1097/INF.0000000000001613.
    PubMed     Text format     Abstract available


  9. CONTRERAS GA, Murphy JR, Heresi GP
    Plasma Interferon Gamma-Inducible Protein 10 (IP10) Level Associates with Abnormal Memory B Cells Phenotypes in Perinatal HIV Infection.
    Pediatr Infect Dis J. 2017 Apr 17. doi: 10.1097/INF.0000000000001612.
    PubMed     Text format     Abstract available


  10. LEVIN C, Le Roux D, Harrison M, Tooke L, et al
    HIV Transmission to Premature Very Low Birth Weight Infants.
    Pediatr Infect Dis J. 2017 Apr 13. doi: 10.1097/INF.0000000000001611.
    PubMed     Text format     Abstract available


  11. KELLY MS, Surette MG, Smieja M, Pernica JM, et al
    The Nasopharyngeal Microbiota of Children with Respiratory Infections in Botswana.
    Pediatr Infect Dis J. 2017 Apr 10. doi: 10.1097/INF.0000000000001607.
    PubMed     Text format     Abstract available


  12. DZIUBAN EJ, DeVos J, Ngeno B, Ngugi E, et al
    High Prevalence of Abacavir-Associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy.
    Pediatr Infect Dis J. 2017 Apr 5. doi: 10.1097/INF.0000000000001597.
    PubMed     Text format     Abstract available


    March 2017
  13. BELARD S, Heller T, Orie V, Heuvelings CC, et al
    Sonographic Findings of Abdominal Tuberculosis in Children with Pulmonary Tuberculosis.
    Pediatr Infect Dis J. 2017 Mar 22. doi: 10.1097/INF.0000000000001590.
    PubMed     Text format     Abstract available


  14. RAMIREZ-AVILA L, Regan S, Cloete C, Crankshaw T, et al
    Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa.
    Pediatr Infect Dis J. 2017;36:311-313.
    PubMed     Text format     Abstract available


    February 2017
  15. OMONI AO, Ntozini R, Evans C, Prendergast AJ, et al
    Child Growth According to Maternal and Child HIV Status in Zimbabwe.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001574.
    PubMed     Text format     Abstract available


  16. NEWMAN LP, Njoroge A, Magaret A, Chohan BH, et al
    Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001572.
    PubMed     Text format     Abstract available


  17. CROWELL CS, Maiga AI, Sylla M, Taiwo B, et al
    High Rates of Baseline Drug Resistance and Virologic Failure Among ART Naive HIV-Infected Children in Mali.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001575.
    PubMed     Text format     Abstract available


  18. SLOGROVE AL, Esser MM, Cotton MF, Speert DP, et al
    A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
    Pediatr Infect Dis J. 2017;36:e38-e44.
    PubMed     Text format     Abstract available


    January 2017
  19. WALTERS E, van der Zalm MM, Palmer M, Bosch C, et al
    Xpert MTB/RIF on Stool is Useful for the Rapid Diagnosis of Tuberculosis in Young Children with Severe Pulmonary Disease.
    Pediatr Infect Dis J. 2017 Jan 31. doi: 10.1097/INF.0000000000001563.
    PubMed     Text format     Abstract available


  20. STALTER RM, Katayamoyo P, Packer C, Banda H, et al
    Transitioning to Second-Line Antiretroviral Therapy Among Adolescents in Copperbelt Province, Zambia: Predictors of Treatment Switching and Adherence to Second-Line Regimens.
    Pediatr Infect Dis J. 2017 Jan 16. doi: 10.1097/INF.0000000000001547.
    PubMed     Text format     Abstract available


  21. DIRAJLAL-FARGO S, Musiime V, Cook A, Mirembe G, et al
    Insulin Resistance and Markers of Inflammation in HIV-Infected Ugandan Children in the CHAPAS 3 Trial.
    Pediatr Infect Dis J. 2017 Jan 6. doi: 10.1097/INF.0000000000001544.
    PubMed     Text format     Abstract available


  22. RAINSBURY PG, Sharp J, Tappin A, Hussey M, et al
    Ritonavir and Topical Ocular Corticosteroid Induced Cushing's Syndrome in an Adolescent with HIV-1 Infection.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001534.
    PubMed     Text format     Abstract available


  23. SHEAHAN A, Feinstein L, Dube Q, Edmonds A, et al
    Early Antiretroviral Therapy Initiation and Mortality Among Infants Diagnosed with HIV in the First 12 Weeks of Life: Experiences from Kinshasa, DR Congo and Blantyre, Malawi.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001539.
    PubMed     Text format     Abstract available


  24. SANYAHUMBI AS, Hosseinipour M, Guffey D, Hoffman I, et al
    HIV Infected Children in Malawi have Decreased Performance on the 6 Minute Walk Test with Preserved Cardiac Mechanics Regardless of Antiretroviral Treatment Status.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001540.
    PubMed     Text format     Abstract available


    December 2016
  25. CURTIS CR, Baughman AL, DeBolt C, Goodykoontz S, et al
    Risk Factors Associated with Bordetella pertussis among Infants Aged </=4 Months in the pre-Tdap Era - United States, 2002-2005.
    Pediatr Infect Dis J. 2016 Dec 28. doi: 10.1097/INF.0000000000001528.
    PubMed     Text format     Abstract available


  26. KOLASA M, Tsai Y, Xu J, Fenlon N, et al
    Hepatitis B surface Antigen Testing Among Pregnant Women, United States 2014.
    Pediatr Infect Dis J. 2016 Dec 27. doi: 10.1097/INF.0000000000001516.
    PubMed     Text format     Abstract available


  27. ABRAMS EJ, Woldesenbet S, Silva JS, Coovadia A, et al
    Despite Access to Antiretrovirals for Prevention and Treatment High Rates of Mortality Persist Among HIV-infected Infants and Young Children.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001507.
    PubMed     Text format     Abstract available


  28. FRIGATI L, Wynberg E, Maritz J, Holgate S, et al
    Antiretroviral Treatment Initiated in the First Month of Life.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001504.
    PubMed     Text format     Abstract available


  29. KEKITIINWA A, Szubert AJ, Spyer M, Katuramu R, et al
    Virologic Response to First-Line Efavirenz- or Nevirapine-Based Anti-Retroviral Therapy in HIV-Infected African Children.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001505.
    PubMed     Text format     Abstract available


  30. JIMENEZ B, Sainz T, Diaz L, Mellado MJ, et al
    Low Bone Mineral Density in Vertically HIV-Infected Children and Adolescents: Risk Factors and the Role of T-Cell Activation and Senescence.
    Pediatr Infect Dis J. 2016 Dec 21. doi: 10.1097/INF.0000000000001506.
    PubMed     Text format     Abstract available


  31. AURPIBUL L, Lumbiganon P, Hansudewechakul R, Kanjanavanit S, et al
    Response to Tenofovir Among Lamivudine-Experienced Hepatitis B and HIV Coinfected Adolescents.
    Pediatr Infect Dis J. 2016 Dec 21. doi: 10.1097/INF.0000000000001491.
    PubMed     Text format     Abstract available


  32. LAZARUS E, Nicol S, Frigati L, Penazzato M, et al
    Second and Third Line Antiretroviral Therapy for Children and Adolescents: A Scoping Review.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001481.
    PubMed     Text format     Abstract available


  33. MAJEKODUNMI AO, Thorne C, Malyuta R, Volokha A, et al
    Hepatitis C Co-Infection and CD4+ T Cell Recovery in HIV-Infected Children Receiving Anti-Retroviral Therapy.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001478.
    PubMed     Text format     Abstract available


  34. JOAO EC, da Silveira Gouvea MI, de Lourdes Benamor Teixeira M, Mendes-Silva W, et al
    Zika Virus Infection Associated with Congenital Birth Defects in a HIV-Infected Pregnant Woman.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001482.
    PubMed     Text format     Abstract available


  35. CAMES C, Pascal L, Diack A, Mbodj H, et al
    Risk Factors for Growth Retardation in HIV-Infected Senegalese Children on Antiretroviral Treatment: The ANRS 12279 MAGGSEN Pediatric Cohort Study.
    Pediatr Infect Dis J. 2016 Dec 13. doi: 10.1097/INF.0000000000001454.
    PubMed     Text format     Abstract available


  36. ATTIA EF, Weiss NS, Maleche-Obimbo E, McGrath CJ, et al
    Risk Factors for Hypoxia and Tachypnea Among Adolescents with Vertically-Acquired HIV in Nairobi.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    November 2016
  37. LORENZO CR, Netto EM, Patricio FR, Brites C, et al
    Survival Estimates and Mortality Risk Factors in a Cohort of HIV Vertically Infected Individuals in Salvador, Brazil.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format    


  38. KENNY J, Doerholt K, Gibb DM, Judd A, et al
    Who Gets Severe Gynecomastia Among HIV-Infected Children In The UK And Ireland?
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  39. SUTCLIFFE CG, Searle K, Matakala HK, Biomed D, et al
    Measles and Rubella Seroprevalence Among HIV-Infected And Uninfected Zambian Youth.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  40. ESPIAU M, Yeste D, Noguera-Julian A, Soler-Palacin P, et al
    Adiponectin, Leptin and Inflammatory Markers in HIV-Associated Metabolic Syndrome in Children and Adolescents.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  41. VUPPULA S, Tyungu D, Kaul A, Chandwani S, et al
    A Thirty-Year Perspective of the Long-Term Survival, CD4 Percentage and Social Achievements of Perinatally HIV- Infected Children as a Function of Their Birth Era.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  42. VIEL-THERIAULT I, Thibeault R, Boucher FD, Drolet JP, et al
    Thalidomide in Refractory Tuberculomas and Pseudoabscesses.
    Pediatr Infect Dis J. 2016;35:1262-1264.
    PubMed     Text format     Abstract available


  43. CYAMATARE RWABUKWISI F, Hedt-Gauthier BL, Ribakare M, Mukamana J, et al
    Five-year Outcomes Among Children Receiving Antiretroviral Therapy in a Community-based Accompaniment Program in Rural Rwanda.
    Pediatr Infect Dis J. 2016;35:1222-1224.
    PubMed     Text format     Abstract available


  44. ARYA BK, Bhattacharya SD, Sutcliffe CG, Kumar Niyogi S, et al
    Impact of Haemophilus influenzae Type B Conjugate Vaccines on Nasopharyngeal Carriage in HIV-infected Children and Their Parents From West Bengal, India.
    Pediatr Infect Dis J. 2016;35:e339-e347.
    PubMed     Text format     Abstract available


    October 2016
  45. OSORIO LE, Boechat MI, Mirochnick M, Kumwenda N, et al
    Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir- Exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network (HPTN) 057.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  46. SMITH ER, Sheahan AD, Heyderman RS, Miller WC, et al
    Performance of HIV Rapid Tests Among Breastfeeding, Malawian Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  47. JACOBSON DL, Patel K, Williams PL, Geffner ME, et al
    Growth at Two Years of Age in HIV-Exposed Uninfected Children in the US by Trimester of Maternal Antiretroviral Initiation.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  48. MAMMEN VG, Dangor Z, Moore DP, Izu A, et al
    Hospitalization for Culture-Confirmed Pulmonary Tuberculosis in the Era of Childhood Pneumococcal Conjugate Vaccine Immunization.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  49. CLARKE DF, Yildirim I, Cooper ER
    Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV Infected Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  50. MATTINGLY AS, Unsal AB, Purdy JB, Gharib AM, et al
    T-Cell Activation and E-Selectin Are Associated with Coronary Plaque in HIV-Infected Young Adults.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  51. MELVIN AJ, Montepiedra G, Aaron L, Meyer WA 3rd, et al
    Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-Infected Children, Adolescents and Young Adults with Hyperlipidemia.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  52. TEASDALE CA, Yang J, Thome B, Yersin I, et al
    Outcomes Among Children Enrolled in HIV Care in Mozambique 2009-2013.
    Pediatr Infect Dis J. 2016;35:1117-25.
    PubMed     Text format     Abstract available


    September 2016
  53. LITTLE KM, Taylor AW, Borkowf CB, Mendoza MC, et al
    Perinatal Antiretroviral Exposure and Prevented Mother-to-Child HIV Infections in the Era of Antiretroviral Prophylaxis in the United States, 1994-2010.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  54. ROSS ECKARD A, Rosebush JC, Lee ST, O'Riordan MA, et al
    Increased Immune Activation and Exhaustion in HIV-Infected Youth.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    August 2016
  55. MOHOLISA RR, Schomaker M, Kuhn L, Castel S, et al
    Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-Experienced HIV-Infected Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  56. CRESSEY TR, Hazra R, Wiznia A, Foca M, et al
    Pharmacokinetics of Unboosted Atazanavir in Treatment-Experienced HIV-infected Children, Adolescents and Young Adults.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  57. ACHAN J, Kakuru A, Ikilezi G, Mwangwa F, et al
    Growth Recovery Among HIV-Infected Children Randomized to Lopinavir/Ritonavir or NNRTI-Based Antiretroviral Therapy.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    July 2016
  58. SAINZ T, Serrano-Villar S, Mellado MJ
    Prevalence of Elevated Blood Pressure in HIV-infected Children, Adolescents and Young Adults.
    Pediatr Infect Dis J. 2016;35:824-5.
    PubMed     Text format    


    June 2016
  59. GONZALEZ-DIAZ M, Urrea-Quezada A, Villegas-Gomez I, Durazo M, et al
    Cryptosporidium canis in Two Mexican Toddlers.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  60. VIEL-THERIAULT I, Thibeault R, Boucher FD, Drolet JP, et al
    Thalidomide in Refractory Tuberculomas and Pseudo-Abscesses.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  61. CYAMATARE FR, Hedt-Gauthier BL, Ribakare M, Mukamana J, et al
    Five-Year Outcomes Among Children Receiving Antiretroviral Therapy in a Community-Based Accompaniment Program in Rural Rwanda.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  62. DZIUBAN EJ, Rivadeneira ED
    Universal Antiretroviral Treatment Eligibility for Children and Adolescents Living with HIV: A New Era.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  63. LOMBAARD J, Bunupuradah T, Flynn PM, Ramapuram J, et al
    Rilpivirine as a Treatment for HIV-infected Antiretroviral-Naive Adolescents: Week 48 Safety, Efficacy, Virology and Pharmacokinetics.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  64. ARYA BK, Bhattacharya SD, Sutcliffe C, Niyogi SK, et al
    Impact of Haemophilus influenzae Type b Conjugate Vaccines (HibCV) on Nasopharyngeal Carriage in HIV Infected Children and Their Parents from West Bengal, India.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  65. VERANI JR, Groome MJ, Zar HJ, Zell ER, et al
    Risk Factors for Presumed Bacterial Pneumonia Among HIV-Uninfected Children Hospitalized in Soweto, South Africa.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    May 2016
  66. VIEIRA MT, Marlow MA, Aguiar-Alves F, Pinheiro MG, et al
    Living Conditions as a Driving Factor in Persistent Methicillin-Resistant Staphylococcus Aureus Colonization Among HIV-Infected Youth.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  67. SONEGO M, Sagrado MJ, Escobar G, Lazzerini M, et al
    Dyslipidemia, Diet, and Physical Exercise in Children on Treatment with Anti-Retroviral Medication in El Salvador: A Cross-Sectional Study.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  68. DAHINTEN AP, Dow DE, Cunningham CK, Msuya LJ, et al
    Providing Safe and Effective Preventative Antiretroviral Prophylaxis to HIV-Exposed Newborns Via a Novel Drug Delivery System in Tanzania.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  69. BASTARD M, Poulet E, Nicolay N, Szumilin E, et al
    Pediatric access and continuity of HIV care before the start of antiretroviral therapy in sub-Saharan Africa.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  70. NYAZIKA TK, Masanganise F, Hagen F, Bwakura-Dangarembizi MF, et al
    Cryptococcal Meningitis Presenting as a Complication in HIV-Infected Children: A Case Series from Sub-Saharan Africa.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  71. FOCA M, Yogev R, Wiznia A, Hazra R, et al
    Rilpivirine Pharmacokinetics Without and With Darunavir/ritonavir once daily in Adolescents and Young Adults.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  72. SCHERPBIER HJ, Terpstra V, Pajkrt D, Puthakanit T, et al
    Noncirrhotic Portal Hypertension in Perinatally HIV-Infected Adolescents Treated with Didanosine-Containing Antiretroviral Regimens in Childhood.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  73. SALOU M, Butel C, Konou AA, Ekouevi DK, et al
    High Rates of Drug Resistance Among Newly Diagnosed HIV-Infected Children in the National Prevention of Mother-To-Child Transmission Program in Togo.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  74. ADACHI K, Klausner JD, Xu J, Ank B, et al
    Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: